Skip to main content

Advertisement

SpringerLink
Log in

Strong Mucosal and Systemic Immunities Induced by Nasal Immunization with Anthrax Protective Antigen Protein Incorporated in Liposome–Protamine–DNA Particles

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Purpose

The very lengthy and complicated dosing schedule of the current anthrax vaccine adsorbed, which was licensed in the USA for the prevention of cutaneous anthrax infection, calls for the development of an efficacious and easily administrable vaccine to prevent against the most lethal form of anthrax infection, the inhalation anthrax. We propose to develop a nasal anthrax vaccine using anthrax protective antigen (PA) protein carried by liposome–protamine–DNA (LPD) particles.

Methods

PA was incorporated in LPD particles and nasally dosed to mice. The resulting PA-specific immune response and lethal toxin neutralization activity were measured.

Results

Mice nasally immunized with PA incorporated into LPD particles developed both systemic and mucosal anti-PA responses. The anti-PA immunities induced included the production of anti-PA antibodies (IgG and IgM in the serum and IgA in nasal and lung mucosal secretions) and the proliferation of splenocytes after in vitro stimulation. The anti-PA IgG subtype induced was mainly IgG1. Finally, anthrax lethal toxin neutralization activity was detected both in the serum and in the mucosal secretions.

Conclusions

The anti-PA immune response induced by nasal PA incorporated in LPD was comparable to that induced by nasal PA adjuvanted with cholera toxin or subcutaneously injected PA adjuvanted with aluminum hydroxide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. T. C. Dixon M. Meselson J. Guillemin P. C. Hanna (1999) ArticleTitleAnthrax N. Engl. J. Med. 341 815–826 Occurrence Handle10.1056/NEJM199909093411107 Occurrence Handle1:STN:280:DyaK1MzptlSnug%3D%3D Occurrence Handle10477781

    Article  CAS  PubMed  Google Scholar 

  2. P. Ascenzi P. Visca G. Ippolito A. Spallarossa M. Bolognesi C. Montecucco (2002) ArticleTitleAnthrax toxin: a tripartite lethal combination FEBS Lett. 531 384–388 Occurrence Handle10.1016/S0014-5793(02)03609-8 Occurrence Handle1:CAS:528:DC%2BD38XosFCks70%3D Occurrence Handle12435580

    Article  CAS  PubMed  Google Scholar 

  3. A. M. Friedlander (1999) ArticleTitleClinical aspects, diagnosis and treatment of anthrax J. Appl. Microbiol. 87 303 Occurrence Handle10.1046/j.1365-2672.1999.00896.x Occurrence Handle10475974

    Article  PubMed  Google Scholar 

  4. G. J. Chaudry M. Moayeri S. Liu S. H. Leppla (2002) ArticleTitleQuickening the pace of anthrax research: three advances point towards possible therapies Trends Microbiol. 10 58–62 Occurrence Handle10.1016/S0966-842X(01)02294-6 Occurrence Handle1:CAS:528:DC%2BD38XhvF2lt7g%3D Occurrence Handle11827799

    Article  CAS  PubMed  Google Scholar 

  5. M. Mourez D. B. Lacy K. Cunningham R. Legmann B. R. Sellman J. Mogridge R. J. Collier (2002) ArticleTitle2001: a year of major advances in anthrax toxin research Trends Microbiol. 10 287–293 Occurrence Handle10.1016/S0966-842X(02)02369-7 Occurrence Handle1:CAS:528:DC%2BD38XkslKhsrs%3D Occurrence Handle12088665

    Article  CAS  PubMed  Google Scholar 

  6. M. Puziss L. C. Manning J. W. Lynch Barclaye I. Abelow G. G. Wright (1963) ArticleTitleLarge-scale production of protective antigen of Bacillus anthracis in anaerobic cultures Appl. Microbiol. 11 330–334 Occurrence Handle1:STN:280:CC2C28vkt1M%3D Occurrence Handle13972634

    CAS  PubMed  Google Scholar 

  7. S. H. Leppla J. B. Robbins R. Schneerson J. Shiloach (2002) ArticleTitleDevelopment of an improved vaccine for anthrax J. Clin. Invest. 110 141–144 Occurrence Handle10.1172/JCI200216204 Occurrence Handle1:CAS:528:DC%2BD38XlsVGlsL0%3D Occurrence Handle12122102

    Article  CAS  PubMed  Google Scholar 

  8. K. A. Bradley J. Mogridge M. Mourez R. J. Collier J. A. Young (2001) ArticleTitleIdentification of the cellular receptor for anthrax toxin Nature 414 225–229 Occurrence Handle10.1038/n35101999 Occurrence Handle1:CAS:528:DC%2BD3MXosFahtrs%3D Occurrence Handle11700562

    Article  CAS  PubMed  Google Scholar 

  9. P. C. Turnbull M. G. Broster J. A. Carman R. J. Manchee J. Melling (1986) ArticleTitleDevelopment of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity Infect. Immun. 52 356–363 Occurrence Handle1:CAS:528:DyaL28Xit1ejsro%3D Occurrence Handle3084381

    CAS  PubMed  Google Scholar 

  10. M. L. Pitt S. F. Little B. E. Ivins P. Fellows J. Barth J. Hewetson P. Gibbs M. Dertzbaugh A. M. Friedlander (2001) ArticleTitleIn vitro correlate of immunity in a rabbit model of inhalational anthrax Vaccine 19 4768–4773 Occurrence Handle10.1016/S0264-410X(01)00234-1 Occurrence Handle1:CAS:528:DC%2BD3MXmsFWrtLo%3D Occurrence Handle11535328

    Article  CAS  PubMed  Google Scholar 

  11. S. Welkos S. Little A. Friedlander D. Fritz P. Fellows (2001) ArticleTitleThe role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores Microbiology 147 1677–1685 Occurrence Handle1:CAS:528:DC%2BD3MXkslSqt74%3D Occurrence Handle11390699

    CAS  PubMed  Google Scholar 

  12. S. Welkos A. Friedlander S. Weeks S. Little I. Mendelson (2002) ArticleTitleIn-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody J. Med. Microbiol. 51 821–831 Occurrence Handle1:CAS:528:DC%2BD38Xps1Kmsb0%3D Occurrence Handle12435060

    CAS  PubMed  Google Scholar 

  13. H. C. Flick-Smith J. E. Eyles R. Hebdon E. L. Waters R. J. Beedham T. J. Stagg J. Miller H. O. Alpar L. W. Baillie E. D. Williamson (2002) ArticleTitleMucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice Infect. Immun. 70 2022–2028 Occurrence Handle1:CAS:528:DC%2BD38Xitl2lsrY%3D Occurrence Handle11895967

    CAS  PubMed  Google Scholar 

  14. J. A. Mikszta V. J. Sullivan C. Dean A. M. Waterston J. B. Alarcon J. P. Dekker Suffix3rd J. M. Brittingham J. Huang C. R. Hwang M. Ferriter G. Jiang K. Mar K. U. Saikh B. G. Stiles C. J. Roy R. G. Ulrich N. G. Harvey (2005) ArticleTitleProtective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms J. Infect. Dis. 191 278–288 Occurrence Handle10.1086/426865 Occurrence Handle1:CAS:528:DC%2BD2MXhtFCqt7k%3D Occurrence Handle15609239

    Article  CAS  PubMed  Google Scholar 

  15. S. F. Little B. E. Ivins P. F. Fellows M. L. Pitt S. L. Norris G. P. Andrews (2004) ArticleTitleDefining a serological correlate of protection in rabbits for a recombinant anthrax vaccine Vaccine 22 422–430 Occurrence Handle1:CAS:528:DC%2BD3sXps1Cjsb4%3D Occurrence Handle14670324

    CAS  PubMed  Google Scholar 

  16. H. Kiyono S. Fukuyama (2004) ArticleTitleNALT- versus Peyer's-patch-mediated mucosal immunity Nat. Rev. Immunol. 4 699–710 Occurrence Handle10.1038/nri1439 Occurrence Handle1:CAS:528:DC%2BD2cXntFCmtL0%3D Occurrence Handle15343369

    Article  CAS  PubMed  Google Scholar 

  17. P. Hellings M. Jorissen J. L. Ceuppens (2000) ArticleTitleThe Waldeyer's ring Acta Otorhinolaryngol. Belg. 54 237–241 Occurrence Handle1:STN:280:DC%2BD3MzisVWiug%3D%3D Occurrence Handle11082757

    CAS  PubMed  Google Scholar 

  18. C. F. Kuper P. J. Koornstra D. M. Hameleers J. Biewenga B. J. Spit A. M. Duijvestijn P. J. Breda Vriesman Particlevan T. Sminia (1992) ArticleTitleThe role of nasopharyngeal lymphoid tissue Immunol. Today 13 219–224 Occurrence Handle1:CAS:528:DyaK38Xlt12ns7o%3D Occurrence Handle1627250

    CAS  PubMed  Google Scholar 

  19. S. S. Davis (2001) ArticleTitleNasal vaccines Adv. Drug Deliv. Rev. 51 21–42 Occurrence Handle10.1016/S0169-409X(01)00162-4 Occurrence Handle1:CAS:528:DC%2BD3MXmtV2ntLs%3D Occurrence Handle11516777

    Article  CAS  PubMed  Google Scholar 

  20. F. L. Jahnsen E. Gran R. Haye P. Brandtzaeg (2004) ArticleTitleHuman nasal mucosa contains antigen-presenting cells of strikingly different functional phenotypes Am. J. Respir. Cell Mol. Biol. 30 31–37 Occurrence Handle1:CAS:528:DC%2BD2cXjvV2jsg%3D%3D Occurrence Handle12829449

    CAS  PubMed  Google Scholar 

  21. R. Gaur P. K. Gupta A. C. Banerjea Y. Singh (2002) ArticleTitleEffect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin Vaccine 20 2836–2839 Occurrence Handle10.1016/S0264-410X(02)00207-4 Occurrence Handle1:CAS:528:DC%2BD38XktVCru70%3D Occurrence Handle12034111

    Article  CAS  PubMed  Google Scholar 

  22. P. N. Boyaka A. Tafaro R. Fischer S. H. Leppla K. Fujihashi J. R. McGhee (2003) ArticleTitleEffective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen J. Immunol. 170 5636– 5643 Occurrence Handle1:CAS:528:DC%2BD3sXjvVynur8%3D Occurrence Handle12759444

    CAS  PubMed  Google Scholar 

  23. N. Lycke (2004) ArticleTitleADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity Ann. N.Y. Acad. Sci. 1029 193–208 Occurrence Handle10.1196/annals.1309.036 Occurrence Handle1:CAS:528:DC%2BD2MXislWisb0%3D Occurrence Handle15681758

    Article  CAS  PubMed  Google Scholar 

  24. K. Fujihashi T. Koga F. W. Ginkel Particlevan Y. Hagiwara J. R. McGhee (2002) ArticleTitleA dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants Vaccine 20 2431– 2438 Occurrence Handle10.1016/S0264-410X(02)00155-X Occurrence Handle1:CAS:528:DC%2BD38XktFKhs7w%3D Occurrence Handle12057597

    Article  CAS  PubMed  Google Scholar 

  25. N. Kadowaki S. Ho S. Antonenko R. W. Malefyt R. A. Kastelein F. Bazan Y. J. Liu (2001) ArticleTitleSubsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens J. Exp. Med. 194 863–869 Occurrence Handle10.1084/jem.194.6.863 Occurrence Handle1:CAS:528:DC%2BD3MXmvFGgs7g%3D Occurrence Handle11561001

    Article  CAS  PubMed  Google Scholar 

  26. Z. Cui L. Huang (2005) ArticleTitleLiposome–polycation–DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: therapeutic effect against cervical cancer Cancer Immunol. Immunother. 54 1180–1190 Occurrence Handle10.1007/s00262-005-0685-2 Occurrence Handle1:CAS:528:DC%2BD2MXhtVylt7fK Occurrence Handle15846491

    Article  CAS  PubMed  Google Scholar 

  27. Y. Tan S. Li B. R. Pitt L. Huang (1999) ArticleTitleThe inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo Hum. Gene Ther. 10 2153–2161 Occurrence Handle10.1089/10430349950017149 Occurrence Handle1:CAS:528:DyaK1MXlvVGrtro%3D Occurrence Handle10498247

    Article  CAS  PubMed  Google Scholar 

  28. Z. Cui R. J. Mumper (2002) ArticleTitleTopical immunization using nanoengineered genetic vaccines J. Control. Release 81 173–184 Occurrence Handle10.1016/S0168-3659(02)00051-2 Occurrence Handle1:CAS:528:DC%2BD38XjtFyhtrc%3D Occurrence Handle11992690

    Article  CAS  PubMed  Google Scholar 

  29. C. Guidi-Rontani M. Weber-Levy E. Labruyere M. Mock (1999) ArticleTitleGermination of Bacillus anthracis spores within alveolar macrophages Mol. Microbiol. 31 9–17 Occurrence Handle10.1046/j.1365-2958.1999.01137.x Occurrence Handle1:CAS:528:DyaK1MXmvVyqtQ%3D%3D Occurrence Handle9987105

    Article  CAS  PubMed  Google Scholar 

  30. P. C. Hanna J. A. Ireland (1999) ArticleTitleUnderstanding Bacillus anthracis pathogenesis Trends Microbiol. 7 180–182 Occurrence Handle10.1016/S0966-842X(99)01507-3 Occurrence Handle1:STN:280:DyaK1MzgvFymsA%3D%3D Occurrence Handle10383221

    Article  CAS  PubMed  Google Scholar 

  31. P. Leone C. G. Janson L. Bilaniuk Z. Wang F. Sorgi L. Huang R. Matalon R. Kaul Z. Zeng A. Freese S. W. McPhee E. Mee M. J. During (2000) ArticleTitleAspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease Ann. Neurol. 48 27–38 Occurrence Handle10.1002/1531-8249(200007)48:1<27::AID-ANA6>3.0.CO;2-6 Occurrence Handle1:CAS:528:DC%2BD3cXltlKquro%3D Occurrence Handle10894213

    Article  CAS  PubMed  Google Scholar 

  32. S. F. Little S. H. Leppla E. Cora (1988) ArticleTitleProduction and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin Infect. Immun. 56 1807–1813 Occurrence Handle1:CAS:528:DyaL1cXksFartLc%3D Occurrence Handle3384478

    CAS  PubMed  Google Scholar 

  33. S. Gurunathan D. M. Klinman R. A. Seder (2000) ArticleTitleDNA vaccines: immunology, application, and optimization* Annu. Rev. Immunol. 18 927–974 Occurrence Handle10.1146/annurev.immunol.18.1.927 Occurrence Handle1:CAS:528:DC%2BD3cXjs1Gmt7w%3D Occurrence Handle10837079

    Article  CAS  PubMed  Google Scholar 

  34. Z. Cui (2005) ArticleTitleDNA vaccine Adv. Genet. 54 257–289 Occurrence Handle16096015

    PubMed  Google Scholar 

  35. Z. Cui S. J. Han D. P. Vangasseri L. Huang (2005) ArticleTitleImmunostimulation mechanism of LPD nanoparticle as a vaccine carrier Mol. Pharm. 2 22–28 Occurrence Handle10.1021/mp049907k Occurrence Handle1:CAS:528:DC%2BD2cXhtVOjt7vN Occurrence Handle15804174

    Article  CAS  PubMed  Google Scholar 

  36. L. Janakova H. Bakke I. L. Haugen A. K. Berstad E. A. Hoiby I. S. Aaberge B. Haneberg (2002) ArticleTitleInfluence of intravenous anesthesia on mucosal and systemic antibody responses to nasal vaccines Infect. Immun. 70 5479–5484 Occurrence Handle10.1128/IAI.70.10.5479-5484.2002 Occurrence Handle1:CAS:528:DC%2BD38XnsV2ls70%3D Occurrence Handle12228273

    Article  CAS  PubMed  Google Scholar 

  37. L. Bracci I. Canini S. Puzelli P. Sestili M. Venditti M. Spada I. Donatelli F. Belardelli E. Proietti (2005) ArticleTitleType I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level Vaccine 23 2994–3004 Occurrence Handle10.1016/j.vaccine.2004.12.006 Occurrence Handle1:CAS:528:DC%2BD2MXivV2iu7c%3D Occurrence Handle15811645

    Article  CAS  PubMed  Google Scholar 

  38. B. Li S. Li Y. Tan D. B. Stolz S. C. Watkins L. H. Block L. Huang (2000) ArticleTitleLyophilization of cationic lipid–protamine–DNA (LPD) complexes J. Pharm. Sci. 89 355–364 Occurrence Handle1:CAS:528:DC%2BD3cXit1KntL8%3D Occurrence Handle10707016

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, 97331, USA

    Brian R. Sloat & Zhengrong Cui

Authors
  1. Brian R. Sloat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhengrong Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhengrong Cui.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sloat, B.R., Cui, Z. Strong Mucosal and Systemic Immunities Induced by Nasal Immunization with Anthrax Protective Antigen Protein Incorporated in Liposome–Protamine–DNA Particles. Pharm Res 23, 262–269 (2006). https://doi.org/10.1007/s11095-005-9078-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-005-9078-7

Key Words

Search

Navigation